drugset / Trial / NCT00402688
An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis
Phase 3
Completed
242 enrolled
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
PriCara, Unit of Ortho-McNeil, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare the safety and effectiveness of levofloxacin 750 mg for 2 weeks or 750 mg for 3 weeks, compared to levofloxacin 500 mg for 4 weeks in the treatment of chronic prostatitis.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-03
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levofloxacin | Small molecule | 500 mg | Oral |
| Comparator | Levofloxacin | Small molecule | 750 mg | Oral |